News: Express Scripts Holding Co (ESRX.O)

ESRX.O on Nasdaq

84.23USD
1 Apr 2015
Change (% chg)

-- (--)
Prev Close
$84.23
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
3,840,424
52-wk High
$88.83
52-wk Low
$64.64

Search Stocks
Select another date:

Mon, Mar 30 2015

UnitedHealth-Catamaran deal sets up healthcare M&A chessboard

NEW YORK - UnitedHealth Group Inc's planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.

UnitedHealth-Catamaran deal sets up healthcare M&A chessboard

NEW YORK, March 30 - UnitedHealth Group Inc's planned takeover of No. 4 U.S. pharmacy benefits provider Catamaran Corp will give the companies added heft in price talks with drug companies, serving as a catalyst for deals allowing other insurers to bulk up.

UPDATE 4-UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 bln

March 30 - Health insurer UnitedHealth Group Inc agreed to buy Catamaran Corp in a deal worth about $12.8 billion to boost its pharmacy benefit business as it competes with bigger rivals such as Express Scripts Holdings Co.

Deals of the day- Mergers and acquisitions

March 30 - The following bids, mergers, acquisitions and disposals were reported by 1400 GMT on Monday:

UPDATE 2-CVS urges cost controls for new cholesterol drugs

Feb 17 - CVS Health warned on Tuesday that the costs of a potent new class of cholesterol treatments could eclipse those of other expensive medicines and overwhelm the U.S. healthcare system "if rigid cost control mechanisms are not put in place."

Big Pharma faces up to new price pressure from aggressive insurers

SAN FRANCISCO - The world's biggest drugmakers face a new reality when it comes to U.S. pricing for their products as insurers use aggressive tactics to extract steep price discounts, even for the newest medications.

Express Scripts sees opportunity to lower cancer treatment cost

- Express Scripts, the largest U.S. pharmacy benefit manager, on Tuesday said cost savings on expensive cancer treatments could be achieved if the company were involved earlier in the decision-making process.

UPDATE 1-Express Scripts sees opportunity to lower cancer treatment cost

Jan 13 - Express Scripts, the largest U.S. pharmacy benefit manager, on Tuesday said cost savings on expensive cancer treatments could be achieved if the company were involved earlier in the decision-making process.

Express Scripts sees opportunity to lower cancer treatment costs

Jan 13 - Express Scripts, the largest U.S. pharmacy benefit manager, on Tuesday said cost savings on expensive cancer treatments could be achieved if the company were involved earlier in the decision-making process.

Exclusive: Express Scripts presses for expansion of drugs it won't cover

LOS ANGELES - Express Scripts, the largest manager of prescription drug plans for U.S. employers, is taking an increasingly aggressive stance in price negotiations with pharmaceutical companies after winning discounts on medications with a strategy introduced last year.

Select another date:
Search Stocks